NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Topoisomerase I Immunoassay   Add to my SOP compendium

BRD ID: 3,039

Source: DCTD Tier: SOP Number of times downloaded: 56

Description

This document describes the procedure for quantifying topoisomerase 1 (TOP1) levels by enzyme-linked immunosorbent assay (ELISA) in tumor biopsy lysates and isolated peripheral blood mononuclear cells (PBMCs). It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD). Visit the DCTD website (https://dctd.cancer.gov/ResearchResources/ResearchResources-biomarkers.htm) for recent updates to the SOP.

Documents for Download

SOP340701_TOP1_IA_D.pdf [Size: 445 KB]
Biospecimens
  • Tissue - Not specified
  • Cell - White Cells
Diagnoses
  • Neoplastic - Not specified
Topics
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!
  • Just Published!
  • April 24, 2024: Biobanking for Precision Medicine Seminar
    • More...